Founded in 1989, Riverside Partners is a Boston-based middle market private equity firm currently investing Riverside Fund VI, L.P. The fund focuses on growth-oriented companies primarily in the healthcare and technology industries. Riverside Partners is particularly experienced at partnering with founders, owners and management teams and it brings substantial domain expertise and operating experience to its portfolio companies.
- Pharmaceuticals
- Biotechnology
- Healthcare
- Information Technology
- Cybersecurity
- Technology Services
- Revenue Cycle Management
- Media Services
- Expense Management
- Labeling Solutions
Leadership
| Name | Title | ||
|---|---|---|---|
| Chintan Meher | Principal |
in/chintan-meher-6b67701
|
|
| Principal |
|
|
|
| Principal |
|
|
|
| Principal |
|
|
|
| Vice President |
|
|
|
| Vice President |
|
|
Recent Transactions involving Riverside Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Riverside Partners to Combine Portfolio Companies, Sequoia Biotech Consulting and Syner-G BioPharma Group, to Create Leading Pharma Services Business |
Syner-G BioPharma GroupSequoia Consulting Group |
Riverside Partners |
Pharmaceutical Consulting Life Sciences Consulting | |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →